Hillcrest Wealth Advisors - NY, LLC Buys iShares China Large-Cap ETF, SPDR Bloomberg Barclays High Yield Bond ETF, iShares Core MSCI Emerging Markets ETF, Sells Bristol-Myers Squibb Co, Financial Select Sector SPDR, Onconova Therapeutics Inc

• New Purchases: JNK, SLV, ONTX,
• Added Positions: VOO, IWM, VEA, FXI, IWN, IWO, IEMG, SDY, VCIT, XBI, VWO, VEU, VGT, IAU, STIP,
• Reduced Positions: SPY, IWF, VUG, GOOGL, XLF, IWB, XLE, XLV, EEM, TIP, MSFT,
• Sold Out: BMY, 0T2,

For the details of Hillcrest Wealth Advisors - NY, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/hillcrest+wealth+advisors+-+ny%2C+llc/current-portfolio/portfolio

1. Vanguard S&P 500 ETF (VOO) - 77,757 shares, 18.19% of the total portfolio. Shares added by 7.16%
2. S&P 500 ETF TRUST ETF (SPY) - 32,335 shares, 8.23% of the total portfolio. Shares reduced by 7.42%
3. Vanguard FTSE All-World ex-US ETF (VEU) - 226,510 shares, 8.19% of the total portfolio. Shares added by 2.04%
4. iShares Russell 2000 ETF (IWM) - 59,720 shares, 7.75% of the total portfolio. Shares added by 8.78%
5. iShares Russell 2000 Value ETF (IWN) - 70,020 shares, 6.66% of the total portfolio. Shares added by 6.38%

Hillcrest Wealth Advisors - NY, LLC initiated holding in SPDR Bloomberg Barclays High Yield Bond ETF. The purchase prices were between $107.7 and $109.72, with an estimated average price of $108.8. The stock is now traded at around $108.710000. The impact to a portfolio due to this purchase was 0.35%. The holding were 5,375 shares as of 2021-09-30.

Hillcrest Wealth Advisors - NY, LLC initiated holding in iShares Silver Trust. The purchase prices were between $19.95 and $24.55, with an estimated average price of $22.48. The stock is now traded at around $22.260000. The impact to a portfolio due to this purchase was 0.24%. The holding were 20,100 shares as of 2021-09-30.

Hillcrest Wealth Advisors - NY, LLC initiated holding in Onconova Therapeutics Inc. The purchase prices were between $3.81 and $6.76, with an estimated average price of $5.18. The stock is now traded at around $3.418100. The impact to a portfolio due to this purchase was 0.04%. The holding were 16,717 shares as of 2021-09-30.

Hillcrest Wealth Advisors - NY, LLC added to a holding in iShares China Large-Cap ETF by 284.55%. The purchase prices were between $38.18 and $46.09, with an estimated average price of $41.31. The stock is now traded at around $41.450000. The impact to a portfolio due to this purchase was 0.41%. The holding were 23,650 shares as of 2021-09-30.

Hillcrest Wealth Advisors - NY, LLC added to a holding in iShares Core MSCI Emerging Markets ETF by 36.04%. The purchase prices were between $60.55 and $66.68, with an estimated average price of $63.66. The stock is now traded at around $63.660000. The impact to a portfolio due to this purchase was 0.24%. The holding were 25,050 shares as of 2021-09-30.

Hillcrest Wealth Advisors - NY, LLC added to a holding in SPDR Biotech ETF by 55.13%. The purchase prices were between $118.69 and $138.49, with an estimated average price of $128.78. The stock is now traded at around $124.840000. The impact to a portfolio due to this purchase was 0.21%. The holding were 8,028 shares as of 2021-09-30.

Hillcrest Wealth Advisors - NY, LLC added to a holding in iShares Gold Trust by 57.49%. The purchase prices were between $32.85 and $34.83, with an estimated average price of $34.07. The stock is now traded at around $34.109900. The impact to a portfolio due to this purchase was 0.12%. The holding were 16,300 shares as of 2021-09-30.

Hillcrest Wealth Advisors - NY, LLC sold out a holding in Bristol-Myers Squibb Co. The sale prices were between $59.17 and $69.31, with an estimated average price of $65.87.

Hillcrest Wealth Advisors - NY, LLC sold out a holding in Onconova Therapeutics Inc. The sale prices were between $3.32 and $5.77, with an estimated average price of $4.41.